JQ1, a well-known BET bromodomain inhibitor, plays a crucial role in regulating arthritis inflammation in bone and joint diseases by blocking IKK-dependent activation of NF-κB signaling in rheumatoid arthritis (39). Here, NFKB1 is linked to arthritic joint disease.